Company Overview

Hims & Hers Health, Inc. is a consumer-focused digital health company operating primarily in the telehealth, online pharmacy, and personalized healthcare industries. The company provides access to medical consultations, prescription medications, and wellness products through its digital platform, targeting conditions that are often underdiagnosed or stigmatized. Its core offerings span dermatology, sexual health, mental health, primary care, and weight management, with revenue largely generated through recurring subscription models and direct-to-consumer sales.

The company operates under the consumer brands Hims, Hers, and Apostrophe, positioning itself as a vertically integrated platform that combines clinical care, technology, and fulfillment. Founded in 2017, Hims & Hers began with a focus on men’s health, later expanding into women’s health and broader primary care services. The company went public in 2021 following a merger with a special purpose acquisition company, accelerating its growth strategy and capital access.

Business Operations

Hims & Hers generates revenue primarily through subscription-based access to healthcare services and products delivered via its digital platform. Its major business lines include virtual medical consultations, prescription medications fulfilled through partner and in-house pharmacy capabilities, and over-the-counter wellness products. The company controls the end-to-end consumer experience, including digital intake, clinician engagement, prescription management, and distribution, which supports customer retention and recurring revenue.

Operations are predominantly U.S.-based, with licensed healthcare providers delivering care across multiple states. Internationally, the company operates on a more limited scale through Honest Health, supporting dermatology-focused services in select markets. Hims & Hers also maintains relationships with third-party manufacturing partners, compounding pharmacies, and logistics providers to support medication production and delivery.

Strategic Position & Investments

Strategically, Hims & Hers is focused on expanding its role as a comprehensive digital healthcare platform by broadening clinical offerings and increasing average revenue per user. Growth initiatives include the expansion of primary care services, mental health treatments, and weight management programs, as well as continued investment in proprietary technology that personalizes treatment pathways and improves clinical efficiency.

The company has pursued selective acquisitions to deepen clinical expertise and accelerate market entry, most notably Apostrophe, which enhanced its dermatology capabilities, and Honest Health, which supported international expansion. Hims & Hers has also invested in emerging treatment categories, including metabolic and weight management therapies, while emphasizing brand trust, regulatory compliance, and long-term customer relationships.

Geographic Footprint

Hims & Hers is headquartered in North America, with its principal executive offices in San Francisco, California. The vast majority of its revenue and operations are derived from the United States, where it maintains nationwide clinical coverage through licensed providers and pharmacy partnerships.

Internationally, the company has a limited but growing presence in Europe, primarily through its ownership of Honest Health in the United Kingdom. While global operations are currently secondary to its U.S. business, international markets represent a potential long-term growth opportunity as regulatory environments and consumer adoption evolve.

Leadership & Governance

Hims & Hers was co-founded by Andrew Dudum, who continues to shape the company’s strategic vision with a focus on accessibility, consumer-centric healthcare, and brand-led growth. The leadership team combines experience in technology, healthcare operations, and regulated industries, supporting the company’s emphasis on scalable and compliant expansion.

Key executives include:

• Andrew Dudum – Co-Founder and Chief Executive Officer
• Oluyemi “Yemi” Okupe – Chief Financial Officer
• Melissa Baird – Chief Operating Officer
• Dr. Patrick Carroll – Chief Medical Officer

The company operates under a governance structure typical of publicly traded healthcare technology firms, with oversight designed to balance innovation, regulatory compliance, and shareholder accountability.